3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
12
Burkitt Lymphoma
8
Lymphoma, Follicular
7
Sarcoma
5
Lymphoma, Non-Hodgkin
5
Hodgkin Disease
5
Neoplasms
4
Lymphoma, B-Cell
4
Lymphoma
4
Endometrial Neoplasms
4
Wilms Tumor
3
Sarcoma, Ewing
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Liposarcoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Ganglioneuroblastoma
2
Fallopian Tube Neoplasms
2
Down Syndrome
2
Dermatofibrosarcoma
2
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Doxorubicin
×
30 days
×
Clear all
No trials found.